Almirall S.A. Total Liabilities
Almirall S.A. total liabilities. Based on the latest financial reports, Almirall S.A. (ALM) has total liabilities worth €882.40 Million EUR (≈ $1.03 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ALM cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Almirall S.A. (2003–2024)
Total liabilities of Almirall S.A. from 2003 to 2024. This chart illustrates how Almirall S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore ALM long-term investment intensity to see how much of total assets are deployed in long-term investments.
Almirall S.A. Competitors by Total Liabilities
The table below lists competitors of Almirall S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Corporación Inmobiliaria Vesta, S.A.B de C.V.
NYSE:VTMX
|
USA | $2.03 Billion |
|
Focuslight Technologies Inc. A
SHG:688167
|
China | CN¥798.49 Million |
|
Lennar Corporation
NYSE:LEN-B
|
USA | $11.94 Billion |
|
Beijing Sinnet Technology Co Ltd
SHE:300383
|
China | CN¥8.17 Billion |
|
Ansell Limited
F:PD1A
|
Germany | €1.34 Billion |
|
CLARIANT ADR 1/SF 4
F:CLRS
|
Germany | €3.69 Billion |
|
AstraZeneca PLC
LSE:AZN
|
UK | GBX65.80 Billion |
|
ZIM Integrated Shipping Services Ltd.
F:2SV
|
Germany | €6.98 Billion |
Liability Composition Analysis (2003–2024)
This chart breaks down Almirall S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Almirall S.A..
Liquidity & Leverage Metrics
Almirall S.A. Total Liabilities Ratios Explained
Almirall S.A. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Almirall S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Almirall S.A. (2003–2024)
The table below shows the annual total liabilities of Almirall S.A. from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €908.28 Million ≈ $1.06 Billion |
-0.36% |
| 2023-12-31 | €911.59 Million ≈ $1.07 Billion |
+9.97% |
| 2022-12-31 | €828.98 Million ≈ $969.16 Million |
-3.12% |
| 2021-12-31 | €855.71 Million ≈ $1.00 Billion |
-13.40% |
| 2020-12-31 | €988.15 Million ≈ $1.16 Billion |
-14.79% |
| 2019-12-31 | €1.16 Billion ≈ $1.36 Billion |
-3.19% |
| 2018-12-31 | €1.20 Billion ≈ $1.40 Billion |
+14.86% |
| 2017-12-31 | €1.04 Billion ≈ $1.22 Billion |
-19.68% |
| 2016-12-31 | €1.30 Billion ≈ $1.52 Billion |
+21.36% |
| 2015-12-31 | €1.07 Billion ≈ $1.25 Billion |
-10.92% |
| 2014-12-31 | €1.20 Billion ≈ $1.40 Billion |
+35.78% |
| 2013-12-31 | €884.39 Million ≈ $1.03 Billion |
+104.51% |
| 2012-12-31 | €432.44 Million ≈ $505.57 Million |
-28.15% |
| 2011-12-31 | €601.89 Million ≈ $703.68 Million |
-16.10% |
| 2010-12-31 | €717.40 Million ≈ $838.72 Million |
-1.99% |
| 2009-12-31 | €732.00 Million ≈ $855.78 Million |
-47.58% |
| 2008-12-31 | €1.40 Billion ≈ $1.63 Billion |
+61.35% |
| 2007-12-31 | €865.45 Million ≈ $1.01 Billion |
+146.60% |
| 2006-12-31 | €350.96 Million ≈ $410.31 Million |
+15.50% |
| 2005-12-31 | €303.85 Million ≈ $355.23 Million |
-9.74% |
| 2004-12-31 | €336.66 Million ≈ $393.59 Million |
-2.41% |
| 2003-12-31 | €344.96 Million ≈ $403.30 Million |
-- |
About Almirall S.A.
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfecti… Read more